For over 75 years, we have been strategically investing in African businesses. BII’s expansive footprint across Africa ...

The arrival of GLP-1 analogue drugs (such as Wegovy) marked a huge shift in the weight loss drug market. These drugs have ...

Non-alcoholic fatty liver disease (NAFLD), recently reclassified as metabolic dysfunction-associated steatotic liver disease ...

Qatar National Vision aims to propel the country forward by balancing the accomplishments that achieve economic growth with ...

Mounjaro was approved by the FDA in May, becoming the first combined GLP-1/GIP agonist to reach the market, but has also benefitted from supply constraints from Novo Nordisk's GLP-1 agonist ...

They are what separate us from the animals. After all, without them, who knows what might happen around a dinner ...

Tirzepatide, a dual GLP-1/GIP agonist, has demonstrated a substantial reduction ... This material from the originating ...

An undersea cable promises to improve Britain’s relationship with Europe, and a poet’s attempt at ornithology is debunked, in Nature’s weekly step back in time. Ecosystem services such as ...

Immunology is the branch of biomedical sciences concerned with all aspects of the immune system in all multicellular organisms. Stockpiled A(H5N1) influenza vaccines made using viruses from the ...

CSL Seqirus, a business of CSL (ASX: CSL), announced today that through its public-private partnership with the Biomedical Advanced Research and Development Authority (BARDA), part of the ...

Nature Research Intelligence gives you a greater focus on real-world impact, enabling you to find the most effective strategies and collaborations to deliver maximum benefit from your research ...